ESR1 and breast carcinoma: Furthermore, Schultz et al. (222) stated that anacardic acid displayed effective inhibition toward estrogen receptor alpha (ERα)-expressing breast cancer cells proliferation, regardless of endocrine/tamoxifen sensitivity, while no effect was observed in ERα-negative cells.